N/A
N=4,832
An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
Chronic Obstructive Pulmonary Disease
Bottom Line
View on ClinicalTrials.gov: NCT03207776 ↗Enrolled (actual)
4,832
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Healthcare Utilization — 1080; 920 Participants — p=0.041
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Usual Care (Other); COPD Clinical Pathway (Other)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Feb 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Healthcare Utilization |
1080; 920 | 0.041 sig |
| SECONDARY Quality, Comfort, and Care (QCC) Defined Readmission Rate |
321; 286 | 0.952 |
| SECONDARY Patient-centric (Protocol Defined) Readmission Rate |
753; 659 | 0.472 |
| SECONDARY 30-day COPD Specific, Acute Care Utilization to Any Hospital Within the System |
240; 179 | 0.544 |
Summary
Patients who are hospitalized at select Carolinas Healthcare System (CHS) sites with Chronic Obstructive Pulmonary Disorder (COPD) acute exacerbation symptoms will be treated per the CHS COPD Clinical Pathway. Patient outcomes will be followed, including but not limited to readmission. Patients on the pathway will also have access to navigator services.
Eligibility Criteria
Inclusion Criteria
- Identified as having an acute exacerbation of COPD within 24 hours of admission
Exclusion Criteria
- Death during the index encounter
- No initial discharge as of the end of the study period
Data sourced from ClinicalTrials.gov (NCT03207776). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.